AKT2 and prostate cancer: In contrast to the distinct functions of AKT1 and AKT2 in breast cancer, both isoforms exhibit a decreasing effect on migration, invasion and focal adhesion by inhibiting the activity of β1-integrin in prostate cancer cells which are also highly hormone-dependent like breast cancer cells.